Inventor · disambiguated record
Ying Li
Also filed as: LI YING · LI YING KI JASON
50 granted patents·23 pending applications·187 citations·filing 2006–2025
98Inventor score
Files withCELGENE CORP20SIGNAL PHARM LLC5UNIV MACAU SCI & TECH5CELGENE CAR LLC4RENSSELAER POLYTECH INST2
Top patents by PatentIndex Score
73 records- 0197US9365524B2Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2015·Granted Jun 14, 2016·22 cites·36 claims
- 0296US9814713B2Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2016·Granted Nov 14, 2017·14 cites·21 claims
- 0395US9221788B2Salts and solid forms of (S)-3-(4- (4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2013·Granted Dec 29, 2015·21 cites·77 claims
- 0494US10278955B1Methods of treating cancerUNIV MACAU SCI & TECH·Filed 2017·Granted May 7, 2019·7 cites·2 claims
- 0593US8802685B2Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesMULLER GEORGE·Filed 2012·Granted Aug 12, 2014·9 cites·61 claims
- 0692US10882867B2Forms and compositions of a MK2 inhibitorCELGENE CAR LLC·Filed 2018·Granted Jan 5, 2021·8 cites·23 claims
- 0792US10626101B2Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2018·Granted Apr 21, 2020·3 cites·10 claims
- 0892US9359364B2Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-oneSIGNAL PHARM LLC·Filed 2014·Granted Jun 7, 2016·10 cites·28 claims
- 0992US9187643B2Silicone based nanocomposites including inorganic nanoparticles and their methods of manufacture and useBENICEWICZ BRIAN C·Filed 2012·Granted Nov 17, 2015·12 cites·21 claims
- 1091US12343346B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2024·Granted Jul 1, 2025·0 cites·7 claims
- 1191US10189808B2Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2017·Granted Jan 29, 2019·10 cites·10 claims
- 1291US9773953B2Organic phosphor-functionalized nanoparticles and compositions comprising the sameRENSSELAER POLYTECH INST·Filed 2014·Granted Sep 26, 2017·7 cites·20 claims
- 1391US9629849B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2015·Granted Apr 25, 2017·7 cites·41 claims
- 1489US10138331B2Matrix-free polymer nanocomposites and related products and methods thereofRENSSELAER POLYTECH INST·Filed 2015·Granted Nov 27, 2018·8 cites·20 claims
- 1588US9403829B2Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their useSIGNAL PHARM LLC·Filed 2012·Granted Aug 2, 2016·13 cites·29 claims
- 1687US9751853B2Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2015·Granted Sep 5, 2017·4 cites·10 claims
- 1787US9249121B2Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2014·Granted Feb 2, 2016·2 cites·53 claims
- 1887US2025281501A1Salts and solid forms of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2025·Application pending·0 cites
- 1986US9969713B2Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2017·Granted May 15, 2018·1 cites·15 claims
- 2084US10463672B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2017·Granted Nov 5, 2019·2 cites·13 claims
- 2183US11629153B2Forms and compositions of a MK2 inhibitorCELGENE CAR LLC·Filed 2020·Granted Apr 18, 2023·1 cites·33 claims
- 2283US10729624B2High-ultraviolet absorption lignin/chemical sun-screening agent microcapsule and preparation method thereforUNIV SOUTH CHINA TECH·Filed 2017·Granted Aug 4, 2020·2 cites·9 claims
- 2383US9884062B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2017·Granted Feb 6, 2018·2 cites·34 claims
- 2480US10787708B2Method of identifying a gene associated with a disease or pathological condition of the diseaseUNIV MACAU SCI & TECH·Filed 2017·Granted Sep 29, 2020·2 cites·12 claims
- 2580US8609632B2Low molecular weight heparin composition and uses thereofSHRIVER ZACHARY·Filed 2007·Granted Dec 17, 2013·6 cites·12 claims
- 2680US2022125797A1Salts and solid forms of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2022·Application pending·0 cites
- 2776US9085551B2Solid forms of 3-(4-nitro-1-oxisoindolin-2-yl)piperidine-2,6-dioneCELGENE CORP·Filed 2013·Granted Jul 21, 2015·1 cites·5 claims
- 2876US8916574B24-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitorsWANG JINGYI·Filed 2010·Granted Dec 23, 2014·3 cites·15 claims
- 2975US2023212137A1Solid forms of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2022·Application pending·0 cites
- 3074US11241439B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2020·Granted Feb 8, 2022·0 cites·12 claims
- 3173US2024092902A1Methods for treating cancer or infection using a combination of an anti-pd-1 antibody, an anti-lag3 antibody, and an anti-tigit antibodyMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 3272US10596180B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl) oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2019·Granted Mar 24, 2020·0 cites·14 claims
- 3372US7910750B2Artemisinin (qinghaosu) derivatives, their preparation methods and their use, and pharmaceutical compositions containing the sameSHANGHAI INST MATERIA MEDICA·Filed 2006·Granted Mar 22, 2011·3 cites·6 claims
- 3472US2011077291A1Preparations of Taxanes for Intravenous Administration and the Preparation Method ThereofCHEN JIANMING·Filed 2009·Application pending·0 cites
- 3571US9278933B2Synthesis of a neurostimulative piperazineVENKATRAMAN SRIPATHY·Filed 2010·Granted Mar 8, 2016·5 cites·3 claims
- 3670US10005760B2Forms and compositions of an ERK inhibitorCELGENE CAR LLC·Filed 2015·Granted Jun 26, 2018·1 cites·21 claims
- 3769US11401257B2Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2020·Granted Aug 2, 2022·0 cites·8 claims
- 3869US10632136B2Soluble dietary fiber and preparation method thereofSHANDONG LONGLIVE BIO TECH CO LTD·Filed 2016·Granted Apr 28, 2020·1 cites·3 claims
- 3968US10702500B2Methods of treating cancerUNIV MACAU SCI & TECH·Filed 2019·Granted Jul 7, 2020·0 cites·7 claims
- 4067US2019216768A1Preparations of taxanes for intravenous administration and the preparation method thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 4166US2018305333A1Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2018·Application pending·0 cites
- 4264US9827243B2Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-oneSIGNAL PHARM LLC·Filed 2016·Granted Nov 28, 2017·0 cites·17 claims
- 4364US2025073209A1COVALENT TARGETING OF RhoA FOR CANCER THERAPYUNIV HONG KONG·Filed 2024·Application pending·0 cites
- 4463US2014045927A1Preparations of taxanes for intravenous administration and the preparation method thereofTIANJIN TASLY GROUP CO LTD·Filed 2013·Application pending·0 cites
- 4561US12427485B2Efficient and stable magnetic nanofiber membrane and preparation method and use thereofUNIV BEIJING NORMAL·Filed 2022·Granted Sep 30, 2025·0 cites·7 claims
- 4659US10604510B2Solid forms comprising (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[B]azepine-4-carboxami compositions thereof, and uses thereofCELGENE CORP·Filed 2019·Granted Mar 31, 2020·0 cites·13 claims
- 4759US10208028B1Methods of treating cancerUNIV MACAU SCI & TECH·Filed 2017·Granted Feb 19, 2019·0 cites·9 claims
- 4859US10202364B2Forms and compositions of an ERK inhibitorCELGENE CAR LLC·Filed 2018·Granted Feb 12, 2019·0 cites·16 claims
- 4959US2025121082A1Anti-cd228 antibody and drug conjugate thereofSHANDONG BOAN BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 5058US2017007570A1Preparations of taxanes for intravenous administration and the preparation method thereofTASLY HOLDING GROUP CO LTD·Filed 2016·Application pending·0 cites
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ying Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →